COVI-COMPLECT: Role of the complement lectin pathway in the pathogenesis of SARS-CoV-2 infection
- Funded by ANR
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19start year
-99Known Financial Commitments (USD)
$0Funder
ANRPrincipal Investigator
Nicole ThielensResearch Location
FranceLead Research Institution
Institut de Biologie Structurale (IBS) - CEA / GrenobleResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Immunity
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
The COVI-COMPLECT project, coordinated by Nicole Thielens (UMR 5075 - Institut de Biologie Structurale (IBS) - CEA / Grenoble) aims to understand the role of the complement lectin pathway, a major player in innate antiviral immune defense, in the pathophysiogenesis of SARS-CoV-2 infection. He proposes to decipher the molecular mechanisms of interactions of SARS-CoV-2 proteins with components of the complement lectin pathway and to assess their functional consequences, including viral neutralization and complement activation. A better understanding of the relative roles of specific complement components, particularly those involved in the activation of the lectin pathway, would be useful in identifying possible patients at risk and in guiding potential therapy targeting the complement.